Press Release|Articles|October 4, 2026

NCPA Foundation Announces 2026 Scholarship Recipients

Listen
0:00 / 0:00

Key Takeaways

  • Scholarship packages combined tuition assistance with convention registration and travel support, positioning recipients for leadership development and deeper engagement with the independent community pharmacy ecosystem.
  • A second cycle of Partners in Pharmacy need-based awards delivered four $10,000 scholarships to students demonstrating both commitment to independent practice and significant financial need.
SHOW MORE

The NCPA Foundation announced the recipients of this year’s NCPA Foundation scholarships.

KANSAS CITY, Mo. (Oct. 4, 2026) – During the National Community Pharmacists Association’s Annual Convention, Oct. 3-6 in Kansas City, Mo., the NCPA Foundation announced the recipients of this year’s NCPA Foundation scholarships. The NCPA Foundation proudly awards scholarships each year to college students pursuing community pharmacy ownership, recognizing those with demonstrated leadership qualities, academic achievement and an interest in independent community pharmacy. Scholarship awardees receive funds to be put toward their school tuition, complimentary registration to this year’s NCPA Annual Convention, and a travel stipend.

For the second time, the NCPA Foundation awarded four Partners in Pharmacy need-based scholarships providing $10,000 to pharmacy students who demonstrate a strong commitment to independent community pharmacy and significant financial need. This additional investment honors the original Partners in Pharmacy Scholarship founders’ intentions to support those students most in need.

“Scholarship support does more than help with the cost of pharmacy school,” said Bill Osborn, PharmD, NCPA Foundation Trustee and Program Committee chair. “It gives students opportunities and the confidence to think bigger about their future. For many student pharmacists, that support can help them see independent community pharmacy ownership as something they can actually achieve.”

Congratulations to the following NCPA student members receiving a 2026 NCPA Foundation scholarship:

  • J.C. and Rheba Cobb Memorial Scholarship in Government Affairs 
    Audrey Calvin, University of North Carolina at Chapel Hill
  • Neil Pruitt Sr. Memorial Scholarship for Entrepreneurism
    Jeremy Cates, Samford University McWhorter School of Pharmacy
  • William B. Simmons Memorial Scholarship in Pharmacy Management 
    Tanvi Patel, Presbyterian College School of Pharmacy

Presidential Scholarship, sponsored by McKesson RxOwnership 

  • Augustine Agyeman, Mercer University College of Pharmacy
  • Erin Dummer, North Dakota State University
  • Ansli McDonald Prickett, Auburn University Harrison College of Pharmacy
  • Sutton Murray, Medical University of South Carolina, College of Pharmacy
  • Kaley Quam, North Dakota State University - College of Pharmacy
  • Faaria Rafat, Roosevelt University College of Science, Health and Pharmacy
    Mackenzie Reinert, Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy
  • Rylee Ugen, Butler University College of Pharmacy and Health Sciences
    Amber Whitten, South University School of Pharmacy

Partners in Pharmacy Scholarship

  • Maci Bradley, The University of Mississippi School of Pharmacy
  • Sandra Fenelon, St. John Fisher University
  • Mallory George, Medical University of South Carolina
  • Britteni Kane, University of Kentucky College of Pharmacy
  • Caitlin Lazaro, University of Washington School of Pharmacy
  • Jansen Rogers, Auburn University Harrison College of Pharmacy
  • Nnenna Ugwa, Howard University College of Pharmacy
  • Katherine Zhou, Duquesne University

Related to this article

Could Linvoseltamab Change When We Treat High-Risk Smoldering Myeloma?
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.